Negotiations between Bayer AG and Monsanto Co. are advancing toward a deal after the companies made progress on issues including the purchase price and termination fee, people familiar with the matter said.
The chief executive officers of Bayer, the German pharmaceutical and chemical company, and Monsanto, the Creve Coeur-based seed company, have had a series of constructive meetings in recent weeks, said the people, who asked not to be identified because the discussions are private.
The companies, in talks to create the world’s largest producer of seeds and pesticides, could reach an agreement in the next two weeks, said the people, who cautioned that negotiations could still fall apart or be delayed.
Bayer has been examining Monsanto’s financial accounts as it weighs a new offer, people familiar with the matter said earlier this month. Monsanto in July rejected Bayer’s improved $55 billion bid, describing the $125-a-share proposal as “financially inadequate.” An agreement would end months of back-and-forth that followed Bayer’s initial offer in May.
Representatives for Bayer and Monsanto declined to comment.
Read more: Bloomberg